Arcutis Biotherapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €771.92M +19.0% €325.52M +21.5% 42.2% +0.0086 pp N/A N/A
    (estimated) €648.67M +27.8% €267.96M +111.9% 41.3% +0.16 pp N/A N/A
    (estimated) €507.69M +34.1% €126.46M +639.0% 24.9% +0.20 pp N/A N/A
    (estimated) €378.54M +31.4% €17.11M -134.7% 4.5% +0.22 pp N/A N/A
    (estimated) €288.17M +70.0% -€49.30M -59.2% -17.1% +0.54 pp N/A N/A
    €169.54M +229.7% -€120.80M -46.6% -71.3% +3.7 pp -€96.62M -54.6% -57.0% +3.6 pp
    €51.42M +1,517.1% -€226.12M -15.8% -439.8% +80 pp -€212.74M +5.2% -413.8% +59 pp
    €3.18M +∞% -€268.66M +50.9% -8,449.8% -84 pp -€202.22M +35.0% -6,360.1% -64 pp
    €0.00 +NaN% -€178.00M +52.1% N/A -€149.77M +54.0% N/A
    €0.00 +NaN% -€117.03M +223.1% N/A -€97.22M +164.9% N/A
    €0.00 +NaN% -€36.23M +118.1% N/A -€36.70M +202.0% N/A
    €0.00 +NaN% -€16.61M +286.8% N/A -€12.15M +273.1% N/A
    €0.00 -€4.29M N/A -€3.26M N/A

    Notifications